Shoji Nakamori

机构：Osaka National Hospital

发表论文 411 篇 · 总被引 14819 次 · h-index 66

代表论文

• Randomized clinical trial of adjuvant gemcitabine chemotherapy versus observation in resected bile duct cancer (2018 · British journal of surgery · 被引 403)
• Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial (2019 · Annals of Oncology · 被引 339)
• Periostin blockade overcomes chemoresistance via restricting the expansion of mesenchymal tumor subpopulations in breast cancer (2018 · Scientific Reports · 被引 76)
• Surgery for Pancreatic Neuroendocrine Tumor G3 and Carcinoma G3 Should be Considered Separately (2019 · Annals of Surgical Oncology · 被引 52)
• Resection for recurrent pancreatic cancer in the remnant pancreas after pancreatectomy is clinically promising: Results of a project study for pancreatic surgery by the Japanese Society of Hepato-Biliary-Pancreatic Surgery (2018 · Surgery · 被引 51)
• nal‐IRI+5‐FU/LV versus 5‐FU/LV in post‐gemcitabine metastatic pancreatic cancer: Randomized phase 2 trial in Japanese patients (2020 · Cancer Medicine · 被引 50)